Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics

被引：0
|
作者：
Abdallah Fayssoil
Olivier Nardi
David Orlikowski
Djillali Annane
机构：
[1] University of Medicine and Dentistry of New Jersey,Intensive Care Unit
[2] Raymond Poincaré Hospital,undefined
[3] AP-HP,undefined
来源：
Heart Failure Reviews | 2010年 / 15卷
关键词：
Duchenne; Dystrophin; Heart failure; ACE inhibitors; Beta-blockers; Experimental therapies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by the absence of dystrophin, a sarcolemmal protein which links the cytoskeleton to the extracellular matrix by interacting with a large number of proteins. Heart failure is a classic complication of this disease. The authors review the pathogenesis and therapeutics of cardiac involvement in DMD.
引用
收藏
页码：103 / 107
页数：4
相关论文
共 50 条
  • [1] Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics
    Fayssoil, Abdallah
    Nardi, Olivier
    Orlikowski, David
    Annane, Djillali
    [J]. HEART FAILURE REVIEWS, 2010, 15 (01) : 103 - 107
  • [2] Therapeutics in Duchenne Muscular Dystrophy
    Strober J.B.
    [J]. NeuroRX, 2006, 3 (2): : 225 - 234
  • [3] CRISPR Therapeutics for Duchenne Muscular Dystrophy
    Erkut, Esra
    Yokota, Toshifumi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [4] Muscle Carnitine Deficiency in Pathogenesis of Myopathy and Cardiomyopathy of Duchenne Muscular Dystrophy
    Zolkipli, Z.
    Mai, L.
    Lamhonwah, A. M.
    Tein, I
    [J]. ANNALS OF NEUROLOGY, 2009, 66 : S140 - S140
  • [5] CARDIOMYOPATHY OF DUCHENNE MUSCULAR-DYSTROPHY - PATHOGENESIS OF LABILE SINUS TACHYCARDIA
    OSHEA, JP
    DORSOGNA, L
    MILLER, G
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (04): : 551 - 551
  • [6] Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response
    Gandhi, Shivam
    Sweeney, H. Lee
    Hart, Cora C.
    Han, Renzhi
    Perry, Christopher G. R.
    [J]. CELLS, 2024, 13 (14)
  • [7] Prevention of cardiomyopathy in Duchenne muscular dystrophy
    Angelini, Corrado
    [J]. LANCET NEUROLOGY, 2015, 14 (02): : 127 - 128
  • [8] CARDIOMYOPATHY IN DUCHENNE MUSCULAR-DYSTROPHY
    SCHMIDTREDEMANN, B
    BECKMANN, R
    SCHAUPETER, W
    SCHMIDTREDEMANN, W
    VOGT, J
    [J]. MEDIZINISCHE KLINIK, 1978, 73 (46) : 1621 - 1626
  • [9] CARDIOMYOPATHY FACTORS IN DUCHENNE MUSCULAR DYSTROPHY
    Gray, A.
    Meaney, F.
    Andrews, J. G.
    Cunniff, C. M.
    Barber, B. J.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (01) : 151 - 151
  • [10] CARDIOMYOPATHY OF DUCHENNE MUSCULAR-DYSTROPHY
    DORSOGNA, L
    OSHEA, JP
    MILLER, G
    [J]. PEDIATRIC CARDIOLOGY, 1988, 9 (04) : 205 - 213
12345